ZA200502005B - Non-sequence complementary antiviral oligonucleotides - Google Patents
Non-sequence complementary antiviral oligonucleotidesInfo
- Publication number
- ZA200502005B ZA200502005B ZA200502005A ZA200502005A ZA200502005B ZA 200502005 B ZA200502005 B ZA 200502005B ZA 200502005 A ZA200502005 A ZA 200502005A ZA 200502005 A ZA200502005 A ZA 200502005A ZA 200502005 B ZA200502005 B ZA 200502005B
- Authority
- ZA
- South Africa
- Prior art keywords
- sequence complementary
- antiviral oligonucleotides
- complementary antiviral
- oligonucleotides
- sequence
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41026402P | 2002-09-13 | 2002-09-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200502005B true ZA200502005B (en) | 2006-05-31 |
Family
ID=35353441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200502005A ZA200502005B (en) | 2002-09-13 | 2005-03-09 | Non-sequence complementary antiviral oligonucleotides |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN1694959A (en) |
ZA (1) | ZA200502005B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR091065A1 (en) * | 2012-05-18 | 2014-12-30 | Replicor Inc | A PHARMACEUTICAL FORMULATION THAT INCLUDES AN ANTIVIRAL OLIGONUCLEOTIDE CHELATE FOR THE TREATMENT OF AN ANTI-VIRAL INFECTION |
-
2003
- 2003-09-11 CN CNA038251337A patent/CN1694959A/en active Granted
-
2005
- 2005-03-09 ZA ZA200502005A patent/ZA200502005B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1694959A (en) | 2005-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003241621A8 (en) | Oligonucleotides having modified nucleoside units | |
GB0405884D0 (en) | Modified nucleotides | |
AU2003237249A1 (en) | Oligonucleotides having modified nucleoside units | |
AU2003224836A8 (en) | Dual-labeled nucleotides | |
ZA200604331B (en) | Diazaindole-dicarbonyl-piperazinyl antiviral agents | |
EP1646371A4 (en) | Antiviral compounds and methods | |
HK1079531A1 (en) | Oligonucleotide conjugates | |
EP1287154A4 (en) | Charge-switch nucleotides | |
GB2422335A8 (en) | Biochip | |
GB0219143D0 (en) | Modified tailed oligonucleotides | |
ZA200502005B (en) | Non-sequence complementary antiviral oligonucleotides | |
EP1613722A4 (en) | Rna-based inhibitory oligonucleotides | |
AU2003223619A1 (en) | Antiviral phosphorothioate oligonucleotides | |
IL182671A0 (en) | Antiviral oligonucleotides | |
GB0322402D0 (en) | HIV pharmaccines | |
IL156330A0 (en) | Article transfer system | |
GB0230037D0 (en) | Modified nucleotides | |
HUE050818T4 (en) | Modified nucleotides | |
GB0327146D0 (en) | Modified nucleotides | |
GB0303924D0 (en) | Modified nucleotides | |
GB0218580D0 (en) | Anti-HIV-1 oligonucleotides | |
GB0317991D0 (en) | Microrna | |
GB0301459D0 (en) | Microrna | |
GB0321391D0 (en) | Flexi-facial plus | |
GB0304450D0 (en) | Concept seven |